Dosing recommendations for ampicillin-sulbactam vary among experts. For highly resistant Acinetobacter infections, some published reports used higher doses than ...

12 июл. 2024 г. · In the present document, guidance is provided on the treatment of infections caused by extended-spectrum β-lactamase-producing Enterobacterales ...

For susceptible A. baumannii isolates, initial therapy typically involves carbapenems like imipenem-cilastatin, meropenem, or doripenem (except ertapenem), ...

19 окт. 2022 г. · In contrast, the guides recommend combination therapy in moderate to severe infections involving at least two antibiotics with in vitro activity ...

The recommended dosages are 2.5–5.0 mg/kg per day of colistin base given in 2–4 divided doses (equivalent to 6.67–13.3 mg/kg per day of CMS) in those with ...

Oral step-down therapy with TMP-SMX or fluoroquinolones has been shown to be a reasonable treatment consideration for Enterobacterales bloodstream infections, ...

In contrast, the guides recommend combination therapy in moderate to severe infections involving at least two antibiotics with in vitro activity – the clinical ...

1 мая 2023 г. · Our preferred regimen consists of high-dose ampicillin-sulbactam, in combination with either cefiderocol, polymyxin B, or tigecycline stratified ...

The currently accepted treatment modality is ampicillin-sulbactam as a monotherapy. Except for patients with a penicillin allergy, combining other antibiotics ...

Guidelines regarding its treatment ... treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex.